Gsa Capital Partners LLP Zai Lab LTD Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2024
A detailed history of Gsa Capital Partners LLP transactions in Zai Lab LTD stock. As of the latest transaction made, Gsa Capital Partners LLP holds 30,635 shares of ZLAB stock, worth $945,089. This represents 0.04% of its overall portfolio holdings.
Number of Shares
30,635
Previous 45,573
32.78%
Holding current value
$945,089
Previous $730,000
27.26%
% of portfolio
0.04%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding ZLAB
# of Institutions
116Shares Held
40.8MCall Options Held
63.1KPut Options Held
420K-
Wellington Management Group LLP Boston, MA7.12MShares$220 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X06.53MShares$201 Million0.06% of portfolio
-
Capital World Investors Los Angeles, CA5.31MShares$164 Million0.02% of portfolio
-
Woodline Partners LP San Francisco, CA2.33MShares$72 Million0.41% of portfolio
-
Viking Global Investors LP2.04MShares$62.9 Million0.14% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.02B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...